• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

两性霉素B、5-氟胞嘧啶和酮康唑治疗实验性隐球菌性脑膜炎

Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.

作者信息

Perfect J R, Durack D T

出版信息

J Infect Dis. 1982 Sep;146(3):429-35. doi: 10.1093/infdis/146.3.429.

DOI:10.1093/infdis/146.3.429
PMID:6286799
Abstract

Ketoconazole, amphotericin B, 5-fluorocytosine, and combinations of these drugs were compared as therapy for chronic cryptococcal meningitis in steroid-treated rabbits. Two hours after treatment of rabbits with meningitis with single drugs the mean cerebrospinal fluid concentration of 5-fluorocytosine was 4.4 microgram/ml, that of amphotericin B was less than 0.3 microgram/ml, and that of ketoconazole ranged from less than 0.2 to 0.8 microgram/ml. Serial quantitative cultures indicated that amphotericin B was the best single-drug regimen. Ketoconazole provided little or no additive effect when used in combination with fluorocytosine or therapeutic doses of amphotericin for two weeks. However, the combination of ketoconazole plus amphotericin B was at least as effective as amphotericin B plus 5-fluorocytosine over a two-week treatment regimen. The addition of ketoconazole to subtherapeutic dose of amphotericin B significantly increased the killing of cryptococci in cerebrospinal fluid.

摘要

酮康唑、两性霉素B、5-氟胞嘧啶以及这些药物的联合用药被用作类固醇治疗的家兔慢性隐球菌性脑膜炎的疗法进行比较。用单一药物治疗患脑膜炎的家兔两小时后,5-氟胞嘧啶的脑脊液平均浓度为4.4微克/毫升,两性霉素B的浓度低于0.3微克/毫升,酮康唑的浓度范围为低于0.2至0.8微克/毫升。系列定量培养表明两性霉素B是最佳的单一药物治疗方案。酮康唑与氟胞嘧啶或治疗剂量的两性霉素联合使用两周时几乎没有或没有相加作用。然而,在为期两周的治疗方案中,酮康唑加两性霉素B的联合用药至少与两性霉素B加5-氟胞嘧啶一样有效。将酮康唑添加到低于治疗剂量的两性霉素B中可显著增强脑脊液中隐球菌的杀灭效果。

相似文献

1
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.两性霉素B、5-氟胞嘧啶和酮康唑治疗实验性隐球菌性脑膜炎
J Infect Dis. 1982 Sep;146(3):429-35. doi: 10.1093/infdis/146.3.429.
2
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.口服氟胞嘧啶与酮康唑联合治疗实验性隐球菌性脑膜炎
J Infect Dis. 1984 Apr;149(4):584-90. doi: 10.1093/infdis/149.4.584.
3
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole.两性霉素B与酮康唑联合治疗实验性组织胞浆菌病和隐球菌病
Rev Infect Dis. 1980 Jul-Aug;2(4):551-58. doi: 10.1093/clinids/2.4.551.
4
Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.用5-氟胞嘧啶和两性霉素B治疗的隐球菌性脑膜炎。
Isr J Med Sci. 1974 Sep;10(9):1148-52.
5
Cryptococcal meningitis--treated with 5-fluorocytosine and amphotericin B (a case report).隐球菌性脑膜炎——采用5-氟胞嘧啶和两性霉素B治疗(病例报告)
J Assoc Physicians India. 1974 Sep;22(9):701-5.
6
Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.用5-氟胞嘧啶和两性霉素B治疗的隐球菌性脑膜炎。
East Afr Med J. 1977 Dec;54(12):684-5.
7
Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS. A randomized trial.氟康唑与两性霉素B加氟胞嘧啶治疗艾滋病患者隐球菌性脑膜炎的比较。一项随机试验。
Ann Intern Med. 1990 Aug 1;113(3):183-7. doi: 10.7326/0003-4819-113-3-183.
8
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.两性霉素B、5-氟胞嘧啶、酮康唑和咪康唑在体外对致病真菌的相互作用。
Antimicrob Agents Chemother. 1982 Nov;22(5):763-70. doi: 10.1128/AAC.22.5.763.
9
Combined activity of amphotericin B and 5-fluorocytosine against Cryptococcus neoformans in vitro and in vivo in mice.两性霉素B与5-氟胞嘧啶联合对小鼠体内外新型隐球菌的活性
J Infect Dis. 1975 Feb;131(2):129-37. doi: 10.1093/infdis/131.2.129.
10
[Amphotericin B and 5-fluorocytosine treatment in renal transplant recipient with cryptococcal meningitis (author's transl)].两性霉素B和5-氟胞嘧啶治疗肾移植受者隐球菌性脑膜炎(作者译)
Taiwan Yi Xue Hui Za Zhi. 1977 Aug;76(8):639-47.

引用本文的文献

1
Pharmacodynamics of ATI-2307 in a rabbit model of cryptococcal meningoencephalitis.ATI-2307 在兔隐球菌性脑膜脑炎模型中的药效学研究。
Antimicrob Agents Chemother. 2023 Oct 18;67(10):e0081823. doi: 10.1128/aac.00818-23. Epub 2023 Sep 20.
2
Oral Lipid Nanocrystal Amphotericin B for Cryptococcal Meningitis: A Randomized Clinical Trial.口服脂质纳米晶两性霉素 B 治疗隐球菌性脑膜炎:一项随机临床试验。
Clin Infect Dis. 2023 Dec 15;77(12):1659-1667. doi: 10.1093/cid/ciad440.
3
Efficacy of APX2039 in a Rabbit Model of Cryptococcal Meningitis.
APX2039 在兔隐球菌性脑膜炎模型中的疗效。
mBio. 2022 Dec 20;13(6):e0234722. doi: 10.1128/mbio.02347-22. Epub 2022 Oct 12.
4
Preclinical Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antifungal Activity of Liposomal Amphotericin B.脂质体两性霉素 B 的临床前安全性、耐受性、药代动力学、药效学和抗真菌活性。
Clin Infect Dis. 2019 May 2;68(Suppl 4):S244-S259. doi: 10.1093/cid/ciz064.
5
Antifungal efficacy of amphotericin B encapsulated fibrin microsphere for treating Cryptococcus neoformans infection in Swiss albino mice.两性霉素B包裹的纤维蛋白微球对瑞士白化小鼠新型隐球菌感染的抗真菌疗效。
Braz J Infect Dis. 2016 Jul-Aug;20(4):342-8. doi: 10.1016/j.bjid.2016.04.006. Epub 2016 Jun 11.
6
New guinea pig model of Cryptococcal meningitis.新型隐球菌性脑膜炎豚鼠模型
Antimicrob Agents Chemother. 2007 Aug;51(8):3011-3. doi: 10.1128/AAC.00085-07. Epub 2007 Jun 11.
7
Antifungal combination therapy: clinical potential.抗真菌联合治疗:临床潜力。
Drugs. 2005;65(11):1461-80. doi: 10.2165/00003495-200565110-00002.
8
Posaconazole and amphotericin B combination therapy against Cryptococcus neoformans infection.泊沙康唑与两性霉素B联合治疗新型隐球菌感染
Antimicrob Agents Chemother. 2004 Sep;48(9):3312-6. doi: 10.1128/AAC.48.9.3312-3316.2004.
9
Combination antifungal therapy.联合抗真菌治疗。
Antimicrob Agents Chemother. 2004 Mar;48(3):693-715. doi: 10.1128/AAC.48.3.693-715.2004.
10
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.新型三唑类药物阿巴康唑对新型隐球菌的体内外疗效
Antimicrob Agents Chemother. 2004 Feb;48(2):384-7. doi: 10.1128/AAC.48.2.384-387.2004.